246 related articles for article (PubMed ID: 21730923)
1. Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study.
Metterlein T; Hartung E; Schuster F; Roewer N; Anetseder M
Minerva Anestesiol; 2011 Aug; 77(8):768-73. PubMed ID: 21730923
[TBL] [Abstract][Full Text] [Related]
2. Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
Johannsen S; Klingler W; Schneiderbanger D; Heiderich S; Roewer N; Schuster F
Acta Anaesthesiol Scand; 2013 Oct; 57(9):1161-6. PubMed ID: 23957432
[TBL] [Abstract][Full Text] [Related]
3. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
[TBL] [Abstract][Full Text] [Related]
4. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
5. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
Hackl W; Winkler M; Mauritz W; Steinbereithner K
Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
[TBL] [Abstract][Full Text] [Related]
6. Contractures in skeletal muscle of malignant hyperthermia susceptible patients after in vitro exposure to sevoflurane.
Snoeck MM; Gielen MJ; Tangerman A; van Egmond J; Dirksen R
Acta Anaesthesiol Scand; 2000 Mar; 44(3):334-7. PubMed ID: 10714850
[TBL] [Abstract][Full Text] [Related]
7. A minimally invasive metabolic test with intramuscular injection of halothane 5 and 6 vol% to detect probands at risk for malignant hyperthermia.
Schuster F; Gardill A; Metterlein T; Kranke P; Roewer N; Anetseder M
Anaesthesia; 2007 Sep; 62(9):882-7. PubMed ID: 17697213
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.
Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621
[TBL] [Abstract][Full Text] [Related]
9. Malignant hyperthermia in humans--standardization of contracture testing protocol.
Melton AT; Martucci RW; Kien ND; Gronert GA
Anesth Analg; 1989 Oct; 69(4):437-43. PubMed ID: 2782643
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular injection of sevoflurane detects malignant hyperthermia predisposition in susceptible pigs.
Schuster F; Metterlein T; Negele S; Gardill A; Schwemmer U; Roewer N; Anetseder M
Anesthesiology; 2007 Oct; 107(4):616-20. PubMed ID: 17893458
[TBL] [Abstract][Full Text] [Related]
11. [High purity ryanodine for in vitro diagnosis of malignant hyperthermia].
Wappler F; Roewer N; Lenzen C; Scholz J; Steinfath M; Rumberger R; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Nov; 28(7):427-31. PubMed ID: 8297948
[TBL] [Abstract][Full Text] [Related]
12. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
Nelson TE; Bedell DM; Jones EW
Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
[TBL] [Abstract][Full Text] [Related]
13. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.
Schuster F; Metterlein T; Negele S; Kranke P; Muellenbach RM; Schwemmer U; Roewer N; Anetseder M
Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individuals.
Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
Eur J Anaesthesiol; 2010 Jan; 27(1):77-82. PubMed ID: 19809329
[TBL] [Abstract][Full Text] [Related]
16. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
Sudo RT; Nelson TE
J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
[TBL] [Abstract][Full Text] [Related]
17. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
[TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
Mortier W; Breucking E
Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201
[TBL] [Abstract][Full Text] [Related]
20. Porcine malignant hyperthermia: cell injury enhances halothane sensitivity of biopsies.
Gallant EM; Fletcher TF; Goettl VM; Rempel WE
Muscle Nerve; 1986 Feb; 9(2):174-84. PubMed ID: 3951491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
